Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats

Indian Journal of Pharmacology

Volumn 47, Issue 1, 2015, Pages 17-21

  Maheshwari, Rajesh A ^a   Balaraman, R ^a   Sailor, Girish U ^a   Sen, Dhanya B ^a  

^a K M SHAH DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Rosuvastatin; Simvastatin; Trinitrobenzene sulfonic acid; Tumor necrosis factor ; Ulcerative colitis

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; ROSUVASTATIN; SIMVASTATIN; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; AUTACOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXIDASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIULCER ACTIVITY; ARTICLE; COLON; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; FECES; FEMALE; HISTOPATHOLOGY; NEUTROPHIL; NONHUMAN; OCCULT BLOOD; OXIDATIVE STRESS; RAT; RECTUM HEMORRHAGE; ULCERATIVE COLITIS; WEIGHT REDUCTION; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; COLITIS, ULCERATIVE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS, ULCERATIVE; COLON; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION MEDIATORS; MALONDIALDEHYDE; NEUTROPHIL INFILTRATION; OXIDATIVE STRESS; PEROXIDASE; RATS, WISTAR; ROSUVASTATIN CALCIUM; SIMVASTATIN; SUPEROXIDE DISMUTASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922966585     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.150311     Document Type: Article

References (22)

1. Da Silva MS, Sánchez-Fidalgo S, Talero E, Cárdeno A, da Silva MA, Villegas W, et al. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby and Grimes in TNBS colitis model. J Ethnopharmacol 2010;128:467-75.
2. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol Suppl 1996;216:149-59.
3. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94.
4. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
5. Katz JA, Itoh J, Fiocchi C. Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 1999;15:291-7.
6. Kolios G, Petoumenos C, Nakos A. Mediators of inflammation: Production and implication in inflammatory bowel disease. Hepatogastroenterology 1998;45:1601-9.
7. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Büschenfelde KH, et al. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997;27:1743-50.
8. Robinson M. Medical therapy of inflammatory bowel disease for the 21 st century. Eur J Surg Suppl 1998;90-8.
9. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334:841-8.
10. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke 2004;35:2902-9.
11. Oda H, Keane WF. Recent advances in statins and the kidney. Kidney Int Suppl 1999;71:S2-5.
12. Naito Y, Katada K, Takagi T, Tsuboi H, Isozaki Y, Handa O, et al. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice. Int J Mol Med 2006;17:997-1004.
13. Arita M, Yoshida M, Hong S, Tjonahen E, Glickman JN, Petasis NA, et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 2005;102:7671-6.
14. Meerveld BG, Tyler KR. CPI-1189 protects against DSS-induced colitis in mice. Am J Pharmacol Toxicol 2006;1:54-9.
15. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogeno alkanes or peroxidative reactions in rat liver fractions in vitro. Biochem J 1971;123:805-14.
16. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
17. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78.
18. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
19. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga C, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg 2003;126:482-9.
20. Kojouharoff G, Hans W, Obermeier F. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997;107:353-8.
21. Takagi T, Naito Y, Tomatsuri N, Handa O, Ichikawa H, Yoshida N, et al. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade. Redox Rep 2002;7:283-9.
22. Kleemann R, Princen HM, Emeis JJ, Jukema JW, Fontijn RD, Horrevoets AJ, et al. Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE∗3-Leiden transgenic mice: Evidence for antiinflammatory effects of rosuvastatin. Circulation 2003;108:1368-74.